Nebojša Manojlović

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

Eric Van Cutsem, Manuel Hidalgo, Jean‐Luc Canon et al. · International Journal of Cancer · 2018 · 105 citations · Full text

Medicine, Oncology, Pharmacology +16

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx ^® ): a placebo-controlled randomised phase II study (PLIANT)

Bengt Glimelius, Nebojša Manojlović, Per Pfeiffer et al. · Acta Oncologica · 2017 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

Tae Won Kim, Anneli Elme, Zvonko Kusić et al. · British Journal of Cancer · 2016 · 72 citations · Full text

Medicine, Cancer Biology, Gastrointestinal Oncology +14

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

Salomon M. Stemmer, Nebojša Manojlović, Mihai Vasile Marinca et al. · Cancers · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer

Tae Won Kim, Anneli Elme, Joon Oh Park et al. · Clinical Colorectal Cancer · 2018 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17